Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy

Similar Items

• CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
  od: Fry, Terry J., i dr.
  Izdano: (2017)
• Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
  od: Shah, Nirali N., i dr.
  Izdano: (2021)
• Flow Cytometric Immunophenotypic Assessment of T-Cell Clonality by V(β) Repertoire Analysis: Detection of T-Cell Clonality at Diagnosis and Monitoring of Minimal Residual Disease Following Therapy
  od: Tembhare, Prashant, i dr.
  Izdano: (2011)
• CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
  od: Shah, Nirali N., i dr.
  Izdano: (2020)
• Modulation of Target Antigen Density Improves CAR T Cell Functionality and Persistence
  od: Ramakrishna, Sneha, i dr.
  Izdano: (2019)